Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Vertex Pharmaceuticals Inc. closed 18.83% below its 52-week high of $519.88, which the company achieved on November 8th.
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?
The fall in CRSP stock can be attributed to a lack of pipeline updates. Despite securing approval for its first marketed product in early 2024, CRSP is yet to record product sales.
BMO lifts Google stock price target on improving Search, cloud, and Youtube trends
In the digital advertising space, YouTube's direct response (DR) strength, especially with QR codes, has been well-received ...
BMO raises Alphabet stock price target on robust growth
BMO Capital Markets maintained their Outperform rating on Alphabet shares (NASDAQ:GOOGL) and increased the price target to $230.00 from the previous $217.00. BMO's analyst cited a positive outlook on ...
Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer
Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more ...